We just received data on a new analyst forecast for $TRMB. Oppenheimer gave a rating of 'Outperform' for $TRMB.
$TRMB Analyst Ratings
Wall Street analysts have issued reports on $TRMB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 07/17/2025
- JP Morgan issued a "Overweight" rating on 05/14/2025
- Piper Sandler issued a "Overweight" rating on 05/08/2025
To track analyst ratings and price targets for $TRMB, check out Quiver Quantitative's $TRMB forecast page.
$TRMB Price Targets
Multiple analysts have issued price targets for $TRMB recently. We have seen 3 analysts offer price targets for $TRMB in the last 6 months, with a median target of $88.0.
Here are some recent targets:
- Kristen Owen from Oppenheimer set a target price of $88.0 on 07/17/2025
- Tami Zakaria from JP Morgan set a target price of $95.0 on 07/10/2025
- Clarke Jeffries from Piper Sandler set a target price of $84.0 on 05/08/2025
$TRMB Congressional Stock Trading
Members of Congress have traded $TRMB stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $TRMB stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
- REPRESENTATIVE APRIL MCCLAIN DELANEY sold up to $15,000 on 02/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$TRMB Insider Trading Activity
$TRMB insiders have traded $TRMB stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $TRMB stock by insiders over the last 6 months:
- ROBERT G PAINTER (President & CEO) has made 0 purchases and 3 sales selling 22,500 shares for an estimated $1,671,450.
- KAIGHAM GABRIEL has made 0 purchases and 2 sales selling 12,514 shares for an estimated $892,626.
- JENNIFER ALLISON (Corporate VP, General Counsel) has made 0 purchases and 3 sales selling 6,727 shares for an estimated $519,414.
- CHRISTOPHER F KEATING (Sr. VP Transportation) sold 5,709 shares for an estimated $411,036
- RONALD BISIO (Sr. Vice President) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $296,625.
- MARK DAVID SCHWARTZ (Senior VP, AECO) has made 0 purchases and 2 sales selling 2,880 shares for an estimated $227,448.
- PETER LARGE (Senior Vice President) has made 0 purchases and 3 sales selling 3,000 shares for an estimated $204,314.
- JAMES CALVIN DALTON has made 0 purchases and 2 sales selling 2,837 shares for an estimated $203,814.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TRMB Hedge Fund Activity
We have seen 355 institutional investors add shares of $TRMB stock to their portfolio, and 287 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GENERATION INVESTMENT MANAGEMENT LLP removed 1,798,211 shares (-19.2%) from their portfolio in Q1 2025, for an estimated $118,052,552
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,445,851 shares (+26.1%) to their portfolio in Q1 2025, for an estimated $94,920,118
- THRIVENT FINANCIAL FOR LUTHERANS removed 1,376,399 shares (-39.4%) from their portfolio in Q1 2025, for an estimated $90,360,594
- CONTOUR ASSET MANAGEMENT LLC removed 1,080,694 shares (-23.1%) from their portfolio in Q1 2025, for an estimated $70,947,561
- SUMITOMO MITSUI TRUST GROUP, INC. removed 972,104 shares (-20.9%) from their portfolio in Q1 2025, for an estimated $63,818,627
- SELECT EQUITY GROUP, L.P. removed 924,525 shares (-9.1%) from their portfolio in Q1 2025, for an estimated $60,695,066
- LAZARD ASSET MANAGEMENT LLC removed 917,429 shares (-32.8%) from their portfolio in Q1 2025, for an estimated $60,229,213
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
